Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
08/2003
08/07/2003US20030149052 Side effect reduction
08/07/2003US20030149043 N-[(substituted five-membered di-or triaza diunsaturated ring)carbonyl] guanidine derivatives for the treatment of ischemia
08/07/2003US20030149041 For prophylaxis and therapy of inflammation, asthma, arthritis, diabetes, atherosclerosis, ocular diseases, restenosis, autoimmune responses, multiple sclerosis, psoriasis, human cancers, fibrosis of liver, lung and kidney
08/07/2003US20030149040 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants
08/07/2003US20030149035 For therapy and prophylaxis of infections by herpesviruses
08/07/2003US20030149029 Administering to a mammal indole derivative compound for therapy of asthma
08/07/2003US20030149025 Use of benzopyranones for treating or preventing a primary brain cancer or a brain metastasis
08/07/2003US20030149023 Novel compounds with analgesic effect
08/07/2003US20030149018 1-aryl- or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
08/07/2003US20030149017 For therapy and prophylaxis of migraine, inflammatory diseases, stroke, acute and chronic pain, hypovolemic shock, traumatic shock, reperfusion injury, Crohn's disease, ulcerative colitis, septic shock, multiple sclerosis, etc.
08/07/2003US20030148888 Novel triazolo pyrimidine compounds
08/07/2003CA2474871A1 Furanone derivatives
08/07/2003CA2474277A1 2,4-pyrimidinediamine compounds and their uses
08/07/2003CA2473169A1 Compounds that inhibit factor xa activity
08/07/2003CA2472340A1 Process for the manufacture of organic compounds
08/06/2003EP1333029A1 Pyrimidine derivatives and herbicides containing the same
08/06/2003EP1332133A1 Metabotropic glutamate receptor antagonists
08/06/2003EP1332131A2 Acid derivatives useful as serine protease inhibitors
08/06/2003EP1332130A2 Atorvastatin hemi-calcium form vii
08/06/2003EP1332127A2 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis
08/06/2003EP1331936A2 Mammalian metabolites of a tachykinin receptor antagonist
08/06/2003EP0994890B1 Benzimidazole derivatives
08/06/2003EP0946538B1 Indane or dihydroindole derivatives
08/06/2003EP0821674B1 Cyclic amidino agents useful as nitric oxide synthase inhibitors
08/06/2003EP0804419B1 Quinoline derivatives as tachykinin nk 3 receptor antagonists
08/06/2003EP0799209B1 Sulfonamides
08/06/2003EP0711762B1 Process for producing tetrazole compounds
08/06/2003CN1434821A Quinazoline derivatives for the treatment of tumours
08/06/2003CN1434818A Novel compounds
08/06/2003CN1434816A Novel compounds
08/06/2003CN1434813A Pyrrolidine derivatives cyclic AMP-specific phosphodiesterase inhibitors
08/06/2003CN1434808A Novel branched substituted amino derivatives of 3-amino-1-phemyl-1HÒÇö1,2,4ÒÇò triazo, methods for producing them and pharmaceutica compositions containing them
08/06/2003CN1434806A Substituted imidazole neuropeptide YY5 receptor antagonists
08/06/2003CN1434805A 选择性神经激肽拮抗剂 Selective neurokinin antagonists
08/06/2003CN1434803A Cyclic lactams as inhibitors os A-alpha protein production
08/06/2003CN1434802A New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
08/06/2003CN1434801A Substited 8-anylquinoline phosphodiesterase-4 inhibitors
08/06/2003CN1434046A Novel intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof
08/06/2003CN1434044A Novel intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof
08/06/2003CN1434043A Novel intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof
08/06/2003CN1434037A Nove intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof
08/06/2003CN1117090C N-acryl-2-substituted-4-(benzimidazolyl-or-imidazopyridinyl-substituted pesidues)-piperidines as tachykinin antagonists
08/06/2003CN1117086C Biphenyl-substituted triazines as light stabilizer
08/06/2003CN1117083C Pyradazin-3-one derivatives, their use, and intermediates for their production
08/06/2003CN1117082C Substituted imidazoles having anti-cancer and cytokine inhibitory activity
08/06/2003CN1117081C Inhibition of raf kinase using aryl and hetroaryl substituted heterocyclic ureas
08/06/2003CN1117077C 6-phenylpyridyl-2-amine derivatives useful asNOS inhibitors
08/05/2003US6603008 Sulfamoylheleroaryl pyrazole compounds as anti-inflammatory/analgesic agents
08/05/2003US6602898 Tricyclic fused heterocycle compounds, process for preparing the same and use thereof
08/05/2003US6602888 Use of α1C specific compounds to treat benign prostatic hyperplasia
08/05/2003US6602886 3-alkyl-3-phenyl-piperidines
08/05/2003US6602879 Pyrrole-type compounds, compositions, and methods for treating cancer or viral diseases
08/05/2003US6602877 Imidazolyl-cyclic acetals
08/05/2003US6602875 Sorbitol dehydrogenase inhibitors
08/05/2003US6602872 Substituted pyridazines having cytokine inhibitory activity
08/05/2003US6602867 Triazole compounds with dopamine-D3-receptor affinity
08/05/2003US6602826 Heterocyclically substituted aromatic amino compounds with a herbicidal effect
08/05/2003CA2264511C Compounds useful for inhibition of farnesyl protein transferase
08/05/2003CA2079373C (azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis
07/2003
07/31/2003WO2003062252A1 Edg receptor agonists
07/31/2003WO2003062230A1 Conbinatorial library of heterocycle compounds
07/31/2003WO2003062229A1 Process for producing dioxolane nucleoside analogues
07/31/2003WO2003062228A1 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatites c virus infection
07/31/2003WO2003062225A1 Pyrimidine derivatives as rho-kinase inhibitors
07/31/2003WO2003062224A1 Aza-cyclic compounds as modulators of acetylcholine receptors
07/31/2003WO2003062223A1 A method of eliminating sulfone analog in the synthesis of pyridine-benzimidazole sulfoxides
07/31/2003WO2003062222A1 Pyrazolecarboxamides, intermediates thereof and pesticides containing the same as the active ingredient
07/31/2003WO2003062211A1 Pyrimidinone viral polymerase inhibitors
07/31/2003WO2003062209A2 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin
07/31/2003WO2003061699A1 Remedies for allergic diseases
07/31/2003WO2003061660A1 Melanocortin receptor agonists
07/31/2003WO2003061658A1 Sigma receptor binder containing indanone derivative
07/31/2003WO2003047516A3 Pyrimidine compounds
07/31/2003WO2003006495A3 Human papillomavirus e2 transactivation domain/inhibitor co-crystal and x-ray coordinates defining the inhibitor-binding pocket
07/31/2003WO2002062762A3 Potassium channel openers
07/31/2003WO2002060875A8 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes
07/31/2003WO2002040471A9 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
07/31/2003WO2002020500A3 Materials and methods to potentiate cancer treatment
07/31/2003WO2001034566A3 Protease inhibitors
07/31/2003US20030144523 Epothilone derivatives, method for producing same and their pharmaceutical use
07/31/2003US20030144522 Substituted N-aryl nitrogen-containing heterocyclic compounds
07/31/2003US20030144519 Process for preparing a piperidine derivative
07/31/2003US20030144507 Sulfonamide-containing heterocyclic compounds
07/31/2003US20030144504 Dialkyl-halogenophenyl-substituted ketoenols
07/31/2003US20030144334 Cyclopentabenzofuran derivatives and their use
07/31/2003US20030144328 Compounds which inhibit leukocyte adhesion mediated by VLA-4
07/31/2003US20030144326 Cyclic amine phenyl beta-3 adrenergic receptor agonists
07/31/2003US20030144320 For treatment and/or prevention of anxiety, mania, depression, panic disorders, nerve sustem disorders
07/31/2003US20030144309 Inhibitors of Src and other protein kinases
07/31/2003US20030144308 Fructose 1,6-bisphosphatase inhibitors
07/31/2003US20030144303 Aminopyrimidine and aminopyridine anti-inflammation agents
07/31/2003US20030144300 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes
07/31/2003US20030144297 Substituted aryl 1,4-pyrazine derivatives
07/31/2003US20030144290 Substituted 2-cyclohexyl-4-phenyl-1H-imidazole derivatives
07/31/2003US20030144289 Dopamine and serotonin reuptake antagonists, used for the prophylaxis of drug abuse or dependence, neurodegenerative diseases or as antidepressants
07/31/2003US20030144286 Nitrogen compounds such as 3-nitro-N-(1H-benzoimidazol-2-yl)-benzamide, used as nonsteroidal antiinflammatory agents, immunology or interleukin receptor associated kinase (IRAK) modulators; rheumatic diseases; multiple sclerosis
07/31/2003US20030144284 Heterocyclic imines such as 2-anilino-6-quinoxalinol, used to suppress cell proliferation, differentiation, chemotaxis and/or activation; prophylaxis of restinosis; anticarcinogenic agents
07/31/2003US20030144282 Inhibitors of cytosolic phospholipase A2
07/31/2003US20030144281 Substituted benzimidazole compounds
07/31/2003US20030144280 Heterocyclic imines, used as cyclooxygenase inhibitors, administered as inflammatory and pain relievers in disorders such as arthritis, neurodegeneration or cancer in mammals
1 ... 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 ... 694